Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

Journal of Clinical Investigation

Volumn 94, Issue 6, 1994, Pages 2493-2503

  Galis, Zorina S ^a   Sukhova, Galina K ^a   Lark, Michael W ^b   Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

atherosclerosis; collagenase; in situ zymography; plaque rupture; vascular remodeling

Indexed keywords

METALLOPROTEINASE;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0028063408     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117619     Document Type: Article

References (28)

1. Glagov, S., E. Weisenberg, C. K. Zarins, R. Stankunavicius, and G. J. Kolettis. 1987. Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. 316:1371-1375.
2. McPherson, D. D., S. J. Sirna, L. F. Hiratzka, L. Thorpe, M. L. Armstrong, M. L. Marcus, and R. E. Kerber. 1991. Coronary arterial remodeling studied by high frequency epicardial echocardiography: an early compensatory mechanism in patients with obstructive coronary atherosclerosis. J. Am. Coll. Cardiol. 17:79-86.
3. Herron, G. S., M. J. Banda, E. J. Clark, J. Gavrilovic, and Z. Werb. 1986. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J. Biol. Chem. 261:2814-2818.
4. Herron, G. S., Z. Werb, K. Dwyer, and M. J. Banda. 1986. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem. 261:2810-2813.
5. Yanagi, H., Y. Sasaguri, K. Sugama, M. Morimatsu, and H. Nagase. 1991. Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis. 91:207-216.
6. Galis, Z. S., M. Muszynski, G. Sukhova, E. Simon-Morrissey, E. N. Unemori, M. W. Lark, E. Amento, and P. Libby. 1994. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75:181-189.
7. Matrisian, L. M. 1992. The matrix-degrading metalloproteinases. Bioessays. 14:455-463.
8. He, C., S. M. Wilhelm, A. P. Pentland, B. L. Marmer, G. A. Grant, A. Z. Eisen, and G. I. Goldberg. 1989. Tissue cooperation in a proteolytic cascade activating human interstital collagenase. Proc. Natl. Acad. Sci. USA. 86:2632-2636.
9. Henney, A. M., P. R. Wakeley, M. J. Davies, K. Foster, R. Hembry, G. Murphy, and S. Humphries. 1991. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA. 88:8154-8158.
10. Chin, J. R., G. Murphy, and Z. Werb. 1985. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J. Biol. Chem. 260:12367-12376.
11. Walakovits, L. A., V. L. Moore, N. Bhardwaj, G. S. Gallick, and M. W. Lark. 1992. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis & Rheum. 35:35-42.
12. Hoyhtya, M., T. Turpeenniemi-Hujanen, W. Stetler-Stevenson, H. Krutzsch, K. Tryggvason, and L. A. Liotta. 1988. Monoclonal antibodies to type IV collagenase recognize a protein with limited sequence homology to interstitial collagenase and stromelysin. FEBS (Fed. Eur. Biochem. Soc.)Lett. 233:109-113.
13. Stetler-Stevenson, W. G., H. C. Krutzsch, and L. A. Liotta. 1989. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264:17374-17378.
14. Ramos-DeSimone, N., U. M. Moll, J. P. Quigley, and D. L. French. 1993. Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody. Hybridoma. 12:349-363.
15. Gross, J., and C. M. Lapiere. 1962. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc. Natl. Acad. Sci. USA. 48:1014-1022.
16. Woessner, J.F., Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB (Fed. Am. Soc. Exp. Biol.) J. 5:2145-2154.
17. Goldberg, G. I., A. Strongin, I. E. Collier, L. T. Genrich, and B. L. Marmer. 1992. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267:4583-4591.
18. Goldberg, G. I., B. L. Marmer, G. A. Grant, A. Z. Eisen, S. Wilhelm, and C. S. He. 1989. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. USA. 86:8207-8211.
19. Libby, P., J. M. Ordovas, L. K. Birinyi, K. R. Auger, and C. A. Dinarello. 1986. Inducible interleukin-1 expression in human vascular smooth muscle cells. J. Clin. Invest. 78:1432-1438.
20. Barath, P., M. C. Fishbein, J. Cao, J. Berenson, R. H. Helfant, and J. S. Forrester. 1990. Detection and localization of tumor necrosis factor in human atheroma. Am. J. Cardiol. 65:297-302.
21. Warner, S. J. C., and P. Libby. 1989. Human vascular smooth muscle cells: Target for and source of tumor necrosis factor. J. Immunol. 142:100-109.
22. Brown, P. D., A. T. Levy, I. M. K. Margulies, L. A. Liotta, and W. G. Stetler-Stevenson. 1990. Independent expression and cellular processing of 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50:6184-6191.
23. Bevilacqua, M. P., R. R. Schleef, M. A. Gimbrone, and D. J. Loskutoff. 1986. Regulation of the fibrinolytic system of cultured vascular endothelium by interleukin 1. J. Clin. Invest. 78:587-591.
24. Davies, M. J., P. D. Richardson, N. Woolf, D. R. Katz, and J. Mann. 1993. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br. Heart J. 69:377-381.
25. Hansson, G. K., J. Holm, and L. Jonasson. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Path. 135:169-175.
26. Richardson, P. D., M. J. Davies, and G. V. Born. 1989. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. 2:941-944.
27. Cheng, G. C., H. M. Loree, R. D. Kamm, M. C. Fishbein, and R. T. Lee. 1993. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathologic correlation. Circulation. 87:1179-1187.
28. Stetler-Stevenson, W. G., L. A. Liotta, and D. E. Kleiner. 1993. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB (Fed. Am. Soc. Exp. Biol.) J. 7:1434-1441.